These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12413924)

  • 1. Reviewing interval cancers: time well spent?
    Lewars MD
    Clin Radiol; 2002 Oct; 57(10):955; author reply 955. PubMed ID: 12413924
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
    Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
    Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
    Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
    Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reviewing interval cancers: time well spent?
    Gower-Thomas K; Fielder HM; Branston L; Greening S; Beer H; Rogers C
    Clin Radiol; 2002 May; 57(5):384-8. PubMed ID: 12014936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UK breast cancer screening programme: an expensive mistake.
    Rodgers A
    J Public Health Med; 1990; 12(3-4):197-204. PubMed ID: 2128025
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiological review of interval cancers in an Australian mammographic screening programme. Radiology Quality Assurance Group of BreastScreen Victoria.
    Amos AF; Kavanagh AM; Cawson J
    J Med Screen; 2000; 7(4):184-9. PubMed ID: 11202584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammograms: when and how often?
    Dest VM
    RN; 2004 Jun; 67(6):26-30; quiz 31. PubMed ID: 15317280
    [No Abstract]   [Full Text] [Related]  

  • 8. Rate and classification of interval cancers in the breast screening programme.
    Sylvester PA; Kutt E; Baird A; Vipond MN; Webb AJ; Farndon JR
    Ann R Coll Surg Engl; 1997 Jul; 79(4):276-7. PubMed ID: 9244072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast-cancer screening with ultrasonography.
    Kopans DB
    Lancet; 1999 Dec 18-25; 354(9196):2096-7. PubMed ID: 10609810
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficiency of single-view mammography: rate of interval cancer cases.
    Lundgren B
    J Natl Cancer Inst; 1979 Apr; 62(4):799-803. PubMed ID: 285293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we undertake an MRI breast screening trial?
    Thorat MA
    Lancet; 2007 Dec; 370(9603):1902; author reply 1903-4. PubMed ID: 18068505
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiological surveillance of interval breast cancers in screening programmes.
    Houssami N; Irwig L; Ciatto S
    Lancet Oncol; 2006 Mar; 7(3):259-65. PubMed ID: 16510335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Previous imaging findings of breast cancers that occurred in combined screening negatives.
    Han BK; Hahn SY; Ko EY; Shin JH; Kang SS
    Eur J Radiol; 2010 Jul; 75(1):e22-8. PubMed ID: 19619968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The visibility of cancer on earlier mammograms in a population-based screening programme.
    Saarenmaa I; Salminen T; Geiger U; Holli K; Isola J; Kärkkäinen A; Pakkanen J; Piironen A; Salo A; Hakama M
    Eur J Cancer; 1999 Jul; 35(7):1118-22. PubMed ID: 10533457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
    Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
    Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancers detected in only one of two arms of a tomosynthesis (3D-mammography) population screening trial (STORM-2).
    Bernardi D; Houssami N
    Breast; 2017 Apr; 32():98-101. PubMed ID: 28107735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening Ultrasound in Women with Negative Mammography: Outcome Analysis.
    Hwang JY; Han BK; Ko EY; Shin JH; Hahn SY; Nam MY
    Yonsei Med J; 2015 Sep; 56(5):1352-8. PubMed ID: 26256979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluating the benefits of mammographic breast cancer screening].
    Kullmann T; Misset JL
    Orv Hetil; 2010 Aug; 151(35):1409-14. PubMed ID: 20719714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline screening mammography with one versus two views.
    Anttinen I; Pamilo M; Roiha M; Soiva M; Suramo I
    Eur J Radiol; 1989 Nov; 9(4):241-3. PubMed ID: 2591390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two models for radiological reviewing of interval cancers.
    Moberg K; Grundström H; Törnberg S; Lundquist H; Svane G; Havervall L; Muren C
    J Med Screen; 1999; 6(1):35-9. PubMed ID: 10321369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.